Sunday, August 4, 2019

Lupin gets EIR from USFDA for Aurangabad facility

Lupin gets EIR from USFDA for Aurangabad facility Lupin said its Aurangabad facility is involved in the manufacturing of oral solid dosage, oral liquid and powder for oral suspension products for the US Market, WHO/Global Institution markets and Indian market.

from Moneycontrol Business News https://ift.tt/2YRb4WV
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...